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Abstract
Respiratory motion during radiotherapy has a significant impact on the dose de-
livered to the targeted volume and surrounding tissue. The accurate treatment of
liver tumours near the diaphragm can be difficult due to large respiratory movement,
as well as the differing tissue densities at the liver/lung interface. The aim of this
project was to evaluate the accuracy of dose delivered to liver tumours using an
in-house respiratory phantom designed to emulate the lung/liver interface.
The phantom consisted of adjacent slabs of liver and lung equivalent materials
and a cam drive system to mimic respiratory motion. Cavities for an ionisation
chamber and Gafchromic EBT3 film were used to perform dosimetric measurements.
Plans were calculated using an Elekta Monaco TPS on the exhale phase study sets
for conformal, VMAT and IMRT techniques, with breathing rates of 8, 14 and
23 breathes per minute. The accuracy of the dose calculated for each treatment
technique was assessed using point dose measurements, gamma analysis of 2D dose
planes and 1D dose profiles.
Analysis confirmed the conformal treatment technique currently used for this
treatment site is suitable. The experiments also determined that VMAT is a viable
alternative method for treatment of superior liver lesions undergoing respiratory
motions, and was superior to IMRT. Furthermore, the measurements highlighted the
need for respiratory management in these cases. Respiratory amplitudes exceeding
the planned displacement could result in reduced coverage of the CTV and much
higher doses to the lung than planned.
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The incidence of cancers of the liver is currently increasing every year in Australia
and many other countries. Hepatocellular lesions are most often treated with surgi-
cal resection, however the use of radiotherapy techniques as an alternative treatment
is on the rise [1]. There are several challenges involved with accurate and effective
radiotherapy treatment to the tumours located within the liver, including the mo-
tion of the tumour due to respiration, very large tumour sizes and radiosensitivity
of the healthy liver tissue.
Successful treatment of liver lesions requires precise delivery of dose to the
tumour, while minimising dose to the surrounding tissue to prevent hepatic tox-
icity. There is currently much discussion in the literature for the optimal method of
achieving this dosimetric outcome.
1.2 Vision of the Project
The current method of treating liver hepatocellular lesions at the Prince of Wa-
les Hospital is using conformal radiation fields with a stereotactic body radiation
therapy (SBRT) technique. Patients are planned using a 4DCT scan and most pa-
tients have respiratory management using Elekta’s Active Breathing Control (ABC)
technology. A custom respiratory phantom was built to ascertain the accuracy of the
Monaco planning system when the liver tumour is very close to the lung interface
by comparing it to the measured delivered dose distribution. The primary aims of
the project are:
• Further validate the current SBRT technique for liver lesions found in the
superior region of the liver.
1
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• Determine if more complex treatment techniques, intensity modulated radia-
tion therapy (IMRT) and volume modulated arc therapy (VMAT), are accep-
table methods for treating this disease type within the department.
• Determine if the rate of respiration affects the dosimetric outcomes.
1.3 Thesis Outline
A review of the literature related to the treatment of hepatocellular tumours using
radiotherapy is discussed extensively in Chapter 2. A description of the software
and equipment used for the project is also discussed. Chapter 3 provides a detailed
account of the design of the in-house built respiratory phantom to be used for
the dosimetric comparisons. This includes construction revisions made prior to
treatment delivery to improve the comparison.
Chapter 4 describes a simple, static experiment performed to better assess how
the dose to the liver will be affected by nearby lung tissue. The experiment was
designed to determine the effect on dose measured by a detector in water equivalent
material if adjacent material is replaced by a low density medium. The effect of
changing parameters including field size, measurement depths and distance from
the interface were analysed.
Chapters 5, 6 and 7 are dedicated to the experimental methodology and results
of the dose comparison for 3D conformal, IMRT and VMAT techniques respectively.
The accuracy of the Monaco planning system in calculating dose in a heterogeneous
medium is investigated as is the effect of motion on the measured dose distribution
for each treatment technique. The significance of motion management with respect
to dosimetric outcomes is also discussed.
The final chapter summarises the results and implications of the project and
identifies potential consequences of the findings as well as recommendations for
future work.
Chapter 2
Review of the Literature
2.1 Radiation Therapy
Radiation therapy, commonly referred to as radiotherapy, is one of the three major
clinical processes available in the treatment of cancer, alongside surgery and che-
motherapy. A 2005 study by Delaney et al. [2] reveals the total number of patients
diagnosed with cancer for whom radiation therapy is indicated, either as a primary
or adjuvant form of treatment, is 53 %. Radiotherapy aims to eliminate disease,
prolong life or palliate symptoms of disease to improve quality of life.
These outcomes are achieved by delivering a controlled dose of radiation to a
well-defined target volume within a patient [3]. There is a higher probability that
energy deposited into a volume will result in cell death, and tumour eradication is
achieved when every tumour cell capable of replication has been killed, or rendered
incapable of viable cell division. Local control is achieved when the tumour regresses
and fails to regrow during the normal lifespan of the patient [4]. Tumour control
probability (TCP) or likelihood a tumour is controlled increases with increasing dose,
as the probability of an individual cancer cell surviving after radiation decreases
exponentially with dose [5]. However, while cancer cells are generally less capable of
repair following radiation than normal tissue, radiotherapy is considered a balancing
act between eradicating the cancer as effectively as possible and sparing the healthy
tissue surrounding the target site.
When radiation treatments are divided into a series of small doses, usually de-
livered in daily sessions, normal tissue cell are given time for repair, and are more
capable of recovery than tumour cells. Even so, the normal tissue complication pro-
bability (NTCP) increases with higher doses. Complications are defined as undesi-
rable effects on healthy tissue or physiological functions, also referred to as toxicity.
The aim of clinicians and researchers is to identify the dose range for each tumour
type and location for which the chance of tumour control is maximised while the
3
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dose to healthy tissue is low enough to avoid unacceptable side effects. This is known
as the therapeutic ratio, and in addition to fractionation, this is achieved through
spatial dose conformity [5].
2.2 External Beam Radiation Therapy
The majority of radiotherapy patients treated in the world today receive external
beam radiation therapy (EBRT) delivered from a medical linear accelerator (linac).
Megavoltage photon energies are used to treat patients with non-superficial targets.
The therapeutic beam is generated by accelerating electrons released via thermionic
emission from an electron gun through a waveguide close to the speed of light,
using a high-power radio frequency source. The electrons collide with a high atomic
number metal target such as tungsten. The majority of electron kinetic energy is
transformed into heat, however a small fraction of this energy is emitted as x-ray
photons via Coulomb interactions within the target. The x-ray beam is then filtered
and collimated to produce a usable, uniform beam, and shaped using block jaws and
multileaf collimators (MLCs) to conform to the target [5].
The development of modern imaging techniques, robust MLCs, accurate beam
modelling and complex treatment planning allows for highly conformal radiation
doses to be delivered to target volumes. External beam radiotherapy has several ap-
pealing characteristics for cancer management; the technique is non-invasive, hence
patients usually do not require hospitalisation, treatment is generally painless, mul-
tiple tumour sites can be treated at each visit and there are often less concurrent
side-effects when compared to surgery and chemotherapy. A major drawback of
EBRT is the dose delivered to the tissue located between the patient skin and tar-
get. This can cause damage to healthy tissue, resulting in late effects and limits the
dose that can be delivered per fraction. This in turn requires the patient to attend
multiple radiotherapy sessions on the order of 5-45 treatments. Hence a major goal
of this modality is to improve dose conformality both to spare normal tissue and
reduce the number of treatment fractions required to be attended by a patient.
Radiotherapy is used in the treatment of many cancer sites including liver can-
cers. Liver cancer incidence is increasing in many countries, predominantly due to
increasing hepatitis C infections [6]. The incidence in Australia is currently incre-
asing each year, with men and the elderly at the greatest risk. Mortality rates are
also comparatively high, with the Australian 5-year relative survival rate from 2007-
2011 at just 16.0 % [7]. While the standard treatment plan for hepatocellular car-
cinoma (HCC) and oligometastatic disease within the liver region involves surgical
resection and liver transplantation, non-surgical alternatives including radiotherapy
are available for inoperable tumours [1]. Despite recent advances in radiotherapy,
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HCC lesions still pose a significant dosimetric challenge, due to high instances of
very large tumour sizes and the high chance of radiation induced liver disease. For
successful local control without serious hepatic toxicities, high local doses must be
delivered to the target while simultaneously sparing healthy hepatic tissue. The
current methods of treatment for these occurrences are discussed below.
2.2.1 Image Guided Radiation Therapy
Image guided radiation therapy (IGRT) involves frequent use of on-board imaging
systems to localise targets during the course of radiotherapy. Image guidance is
used prior to treatment delivery to accurately align the patient by matching selected
internal structures to the same structures on the planning CT data. Imaging may
also be used during and after treatment to determine if any movement has occurred
during the treatment, or to monitor unavoidable, reproducible organ motion, most
notably due to respiration. IGRT improves both precision and accuracy of treatment
delivery by aligning internal structures, rather than exterior structures such as tattoo
markers and distances to skin. This was originally achieved through aligning bone
anatomy through MV planar images taken with on-board electronic portal imaging
devices (EPIDs). The development of advanced cone-beam CT (CBCT) devices
as standard imaging mounted on modern linacs allows for a direct registration of
planning target volumes and soft tissue structures. IGRT can be used in combination
with each of the techniques discussed below.
2.2.2 3D Conformal Therapy
Three-dimensional conformal radiotherapy (3DCRT) is the conventional radiother-
apy treatment technique. This image-based method involves using a computerised
radiotherapy treatment planning system (TPS) to calculate an appropriate, patient
specific treatment plan, allowing conformity of the treatment beam to the geometric
shape of the tumour. Computed tomography imaging is primarily used for planning
with a radiation oncologist delineating a series of volumes surrounding the tumour to
be targeted. Additional imaging techniques such magnetic resonance imaging (MRI)
and positron emission tomography (PET) may be fused to the planning CT scan to
better visualise the tumour volume. Margins are added to the visible tumour to ac-
count for microscopic spread of the disease, set-up errors, patient motion and other
uncertainties. Organs at risk surrounding or close to the target are also contoured
to best ensure dosimetric constraints are met.
The target is irradiated from a series of static beam angles around the patient,
as shown in figure 2.1. This results in a dose to all healthy tissue in the path of
the beam, but a much higher dose to the target over the summation of all beams
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Figure 2.1: 3DCRT treatment plan with fields at discrete, static gantry angles
[8]. Treatment fields are manually placed on by the planner and MLCs are ported
to conform to the shape of a target volume, a process known as forward planning.
Standard beam configurations are generally used with arrangements as few as 2 fields
for treating the breast and limbs, and 5 and 7 field arrangements for deep seated
tumours such as liver and lung tumours. Beams are weighted based on the tumour
depth at that angle, tumour size and shape and the presence of OARs in the path
of the beam. The TPS algorithm then calculates the dose distribution within the
patient and this is compared with the radiation oncologist’s prescription and OAR
constraints. Plan optimisation is limited for 3D conformal therapy to adjustment of
beam shapes, directions and application of a wedge in the beam. Placing a wedge
within the beam creates an intensity gradient across the field to modulate the dose
within the beam. A plan’s quality is assessed by examining the dose coverage of
the planning target volume as prescribed by the radiation oncologist using isodose
displays, dose volume histograms and structure statistics.
The ability to closely conform a high radiation dose to a localised target within
the liver has greatly contributed to increased use of radiotherapy to treat HCC.
Research has showed that use of simple, conformal techniques such as parallel op-
posed fields entering through the anterior and posterior directions (AP-PA beams)
are ineffectual in controlling HCC primary tumours of the liver. Additionally, radi-
ation to the entire liver volume with high dose was shown to result in unacceptably
high acute and late hepatic toxicity, particularly radiation-induced liver disease [8].
However, conformal radiotherapy involving additional beams, allows dose escalation
to the planning target volume (PTV) to reduce the risk of recurrence while simulta-
neously reducing the dose to the surrounding healthy liver tissue to reduce toxicity
effects. This can significantly increase the quality of life and survival times for some
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patients with primary HCC disease [9].
2.2.3 Intensity Modulated Radiation Therapy
Intensity modulated radiation therapy (IMRT) is a revolutionary treatment techni-
que that often delivers superior clinical results when compared to 3D conformal
therapy, particularly for complex treatment sites. IMRT uses various methods to
modulate delivered intensity radiation, allowing for tightly conformal dose distribu-
tions. The primary method of achieving this is by using the MLC to segment the
beam into small beamlets, thereby varying the beam intensity across a field for a
single gantry angle. A comparison of dose distributions for a conformal beam and an
IMRT beam is seen in figure 2.2, taken from PTW Verisoft patient quality assurance
software.
IMRT planning utilises iterative plan optimisation strategies to achieve plan
aims. Where traditional or forward planning required the user to manually optimise
beam placement, weighting and use of beam modifiers, inverse treatment planning
(ITP) is an automated optimisation process. ITP starts with the user defining a
set of dose constraints in the form of dose coverage and limits, which the computer
algorithm will try to achieve within the limitations of IMRT delivery. This is usually
achieved through an iterative process in which the plan quality is evaluated by an
objective function. The algorithm must also translate the produced intensity map
for each beam into appropriate MLC segment sequencing, usually with an objective
to minimise the number of segments, “beam-on” time and total treatment times.
The calculation of planning times is increased for IMRT plans, however the time to
set up the calculation by the planner may be significantly reduced.
By allowing additional degrees of freedom for dose shaping, IMRT improves
both target volume conformity and normal tissue complication. This can result in
improvements in local control and reduction in acute and late toxicities [10]. Ad-
ditionally, IMRT facilitates different doses delivered to different target areas during
a single treatment fraction. This could allow for local treatment boosts without
increasing treatment times or number of fractions, which could have a significant,
positive radiobiological effect. Due to the higher number of monitor units delivered
however, the total treatment time is increased. This results in higher levels of scat-
tered and leakage radiation to out of field regions. Longer treatment times can also
result in increased patient intrafraction motion, reducing the positional accuracy,
which is critical in IMRT, although this is being improved through image guidance
and patient fixation. Further disadvantages include the time and resource-heavy
planning calculations and patient-specific QA, issues which are being addressed by
vendors through faster algorithms, hardware upgrades and 2D and 3D dosimetry
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Figure 2.2: A 3D representation of delivered radiation beam intensities for an
individual conformal beam (left) and an IMRT beam (right).
tools [3]. It is standard practice (and in some cases mandatory) to perform dosi-
metric verification of individual treatment plans when using complex intensity mo-
dulation techniques. This process usually involves point dose measurements with
an ionisation chamber placed within a suitable phantom and dose profiles in one or
more planes with a suitable detector such as diode or ionisation chamber arrays, or
radiochromic film [11].
Complex, intensity-modulated dose distributions are achieved primarily through
MLC modulation, with recent linacs now having advanced MLCs as standard issue
and treatment planning systems accurately able to model them. MLC modulation
is a convenient method due to automated treatment planning optimisation, ability
to create many segments per treatment of very different shapes and sizes, and no
requirement for manual management of treatment aids during treatment. MLC
modulation can be further divided into static and dynamic techniques. Segmental
IMRT, known as the step and shoot method, is characterised by the MLC shape
remaining static during irradiation. This method is a basic extension of conformal
treatment but at each gantry angle there are multiple MLC shapes, known as seg-
ments or beamlets. The radiation beam is paused while the MLCs move to the
next segment position. For dynamic or sliding window methods the movement of
the MLC’s is continuous during irradiation, resulting in a continuously varied in-
tensity fluence. Both leaf speed modulation and dose rate modulation are required
to achieve the desired intensity distribution. Dynamic methods deliver a smooth
intensity variation, generally more efficient than static methods, and are usually
delivered in shorter time. However, the delivery mechanism is more complex and
requires additional and more rigorous quality assurance. The total number of MUs
is also greater, resulting in increased out of field doses which can increase the risk
of secondary malignancies. It is also potentially more difficult to recover from inter-
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rupted beams [12].
The IMRT treatment technique has been shown by Thomas et al. [13] to offer
improved treatment plans for liver tumours when compared to conformal plans with
the same, conventional fractionation schemes. The use of inverse planning and
intensity modulation increases the degrees of freedom for dose deposition within
the target. As there exists a large variability amongst patients with liver cancers
in terms of the location of the tumour site within the liver, the distance of the
tumour to OARs, the total volume of the liver and the number of tumour sites,
standard beam arrangements may prove inadequate. A superior plan can often be
achieved through IMRT using an iterative, individualised approach[14]. For tumour
sites located close to at-risk organs including the stomach, duodenum, spinal cord,
kidneys and lung, IMRT allows for shaping of the isodose curves to reduce the dose
delivered to these structures and avoid exceeding recommended dose limits. In the
cases that the liver itself is the dose limiting structure, the ability to vary dose
delivered across the target may increase the allowable target dose, particularly for
small tumour sites [13].
2.2.4 Volumetric Modulated Arc Therapy
Volume-modulated arc therapy (VMAT) aims to overcome many of the disadvan-
tages of fixed gantry IMRT. Arc therapy delivers radiation uninterruptedly with
continuous gantry rotation through an arc or multiple arcs up to 360o, unlike con-
ventional IMRT which delivers dose at a relatively small (usually less than 12)
number of fixed gantry angles. VMAT is characterised by the ability to vary MLC
segment shapes, dose rate and gantry rotational speed simultaneously during treat-
ment. The main advantge of VMAT over IMRT is much greater efficiency through
reduced MUs and total treatment time. This in turn reduces the integral body dose
and allows for higher patient capacity and increased time for IGRT and patient set
up [15]. But with the introduction of another moving parameter, the quality as-
surance timing and resources are greatly increased, particularly for patient-specific
QA. However this disadvantage is offset somewhat by the shorter treatment times,
and introduction of new dosimetry techniques and tools such as EPID dosimetry
and 3 dimensional dosimeters such as the ArcCheckTM and OctaviusTM systems.
A study by Xi et al [16] compares 3DCRT and VMAT for patients with unresec-
table HCC. The study found the high-dose region of healthy liver volume receiving
30% of the prescription dose (V30) was lower for VMAT, however low dose regions
receiving 10 Gy and 5 Gy were much higher the 3DCRT. The study also concluded
that the whole group comparison showed statistically significant improvements in
dose coverage, conformity and homogeneity of the PTV for VMAT plans, while also
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achieving improved sparing of all serial organs at risk.
2.2.5 4D IGRT and Motion Management
Intra-abdominal respiratory motion is one of the most significant factors affecting
the treatment of HCC with external beam radiation therapy. Large margins must
be added to target volumes to account for tumour motion, adding to the amount of
healthy liver tissue receiving the prescribed dose. Various studies have recorded liver
movements of up to 8 cm in the superior-inferior direction [8], however an average
displacement appears to be 1 - 2 cm with at least some movement observed in most
patients [17, 18]. 4D treatments require a 4DCT acquisition for treatment planning
in order to contour the clinical target volume (CTV) at all positions within the body
and generate an internal target volume (ITV) that accounts for the motion of the
tumour by summing the CTV location at each phase of the breathing cycle. A PTV
contour is then generated by adding a suitable margin to the ITV to account for
external treatment inaccuracies, such as set up errors. Ideally, 4D CBCT will be
used during treatment to align the patient and ensure the CTV is always moving
within the planned treatment volume. Additional measures such as implantation of
fiducial markers may be considered if soft tissue visualisation on CBCT is expected
to be poor. Respiratory management should also be employed where possible for
these treatment sites due to respiration.
Different methods are used during radiotherapy to manage respiratory motion
during abdominal treatments. These methods are designed to either minimise or
monitor patient motion, or track the tumour. Respiration limiting techniques use
breathing techniques or physical devices to limit the respiratory motion during treat-
ment in order to reduce treatment margins and hence reduce dose to healthy tissue.
One technique is breath hold, which involves the patient holding their breath in a
reproducible position during CT and treatment. This allows reduction in tumour
margins however can add significant time to the patient treatment and may be re-
strictive for large doses delivered during SBRT. The effect of constantly pausing the
beam for modulated fields should also be considered. Another example is forced
shallow breathing and abdominal compression which has been shown to effectively
reduce liver tumour motion, however requires specialised equipment and training to
ensure compression level and position is reproducible [19]. Monitoring a patient’s
breathing during treatment with devices such as spirometers or bellows, allows staff
to measure the patient respiratory amplitude to ensure the tumour travels within
the PTV. The Elekta Active Breathing Control system monitors the inspiration vo-
lume of a patient during the planning CT acquisition. From the breathing trace, a
breathing threshold can be set. The patient is monitored during treatment using
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the same equipment set up to ensure their air uptake does not exceed that mea-
sured during simulation. If the patient’s breathing becomes too deep or irregular,
the radiation beam can be paused, since it implies the CTV is moving out of the
treatment field.
Tumour tracking methods can also be used to reduce tumour margins. Gating
involves monitoring a patient’s breathing cycle and beaming on, either manually or
automatically, when the breathing cycle is within a specific gating window. Tumour
tracking is a relatively new technique also involving monitoring the breathing cycle,
however uses real-time tracking to shape the MLC to the current tumour position
throughout the respiration cycle, allowing much faster treatment delivery times.
These methods require specialised equipment and are highly reliant on the radiation
beam and imaging capabilities of the treatment machine [18, 20].
Interplay effects arise when motion is present in modulated fields. Tumour mo-
vement relative to the MLC motion causes interplay effects, with the impact most
significant for highly modulated fields and in heterogeneous mediums. This is parti-
cularly relevent for liver IMRT and VMAT treatments. The effect is also increased
for hypofractionated treatments and larger motion displacement [20]. Respiration
suppression methods discussed aboved can be used to help reduce these effects.
2.2.6 Stereotactic Body Radiation Therapy
Stereotactic body radiation therapy (SBRT), often used interchangeably with stere-
otactic ablative radiotherapy (SABR), is a relatively new external beam treatment
which precisely delivers a very high dose of radiation to a target in only a few fracti-
ons, giving a high biological effective dose (BED). SBRT is characterised by high
precision, image-guided dose delivery to extracranial targets within the body [21,
22]. Very conformal doses with steep dose gradients are achieved through specialised
treatment planning and motion management. This technique is generally for one or
more small, well-defined lesions in the body to reduce dose to healthy surrounding
tissues. SBRT can theoretically be applied to any extracranial site, and has been
shown to be very effective in controlling early stage primary and oligometastatic
cancers in abdominopelvic sites including the spine [21].
A significant reduction in precision for abdominopelvic tumours is intrafraction
motion, predominantly due to respiration. Liver tumours undergo translations, ro-
tation and hysteresis with the largest motion in the superior-inferior direction [23].
Increasing the PTV substantially to ensure tumour coverage at all phases is unde-
sirable for SBRT hence motion management is essential. SBRT allows an increased
BED delivery which has been shown to increase local control rates for HCC[1] and
reduces dose to healthy liver tissue. Given the highly radiosensitive nature of the li-
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ver, dose escalation can be inhibited by the normal tissue complication doses. Hence,
SBRT with motion management is a superior radiotherapy technique for treatment
of inoperable HCC tumours and oligometastases as it reduces the normal tissue dose
through highly conformal dose distributions and delivers a high BED to the target,
correlating with better local control [1].
Standard linacs with image guided technology are normally adequate for this
type of treatment technique. The small tumour sizes targeted during SBRT and an
enhanced need for conformity necessitate a maximum planning CT slice thickness
of 3 mm, with 2 mm or less preferable [24]. 4DCT capabilities with respiratory ma-
nagement systems such as Varian’s RPM system are also highly recommended for
liver target volumes because of the probability of large target displacement during
respiration. Treatment planning systems must be capable of image fusion and accu-
rately model small field dosimetry. A grid size of 2 mm or finer is recommended by
the AAPM (101) [21] to achieve a suitable dose distribution resolution. Personalised
immobilisation and stabilisation are essential for reproducible SBRT delivery. Cus-
tom supports such as vacuum bags that provide indexed, full-length patient support
are recommended for liver patients to ensure both patient position reproducibility
and comfort, which can assist in reducing intrafraction movement [24].
2.3 EBRT Planning Systems
Dose calculation algorithms used in modern external beam treatment planning sy-
stems can be essentially assigned into two classes; correction-based (also called
measurement-based) algorithms and model-based algorithms. The correction-based
method preceded the latter and is used less often in modern treatment planning
systems. 3D model-based TPS algorithms are a more complex dose calculation, and
represent the modern approach to radiotherapy treatment planning. Calculations
such as Collapsed-Cone convolution, Superposition and Monte Carlo are found in
many commercially available systems. These algorithms take into account particle
transport away from the main interaction sites, modelling scatter contribution to
absorbed dose and hence giving a more accurate representation of the true dose
distribution within a patient. ICRU report 50 [25] recommends that the delivered
dose be within + 7% and - 5% of the prescribed dose.
Modern CT techniques allow the full volume and geometry of a patient to be
accounted for and accurate fluence calculations based on the assigned mass attenu-
ation coefficient per voxel. Various dose algorithms exist which are commonly used
in modern TPS and independent dose calculation software. The plan calculation
times generally increase with increased dose accuracy, particularly in areas of inho-
mogeneity such as lung and head and neck sites [26].
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2.3.1 Monte Carlo Dose Calculation Algorithm
Monte Carlo based dose calculation represents a direct approach to solving the
transport equation for individual patient geometry and heterogeneities. The algo-
rithm simulates the path of an individual particle (namely photons and electrons)
through a specified volume. The particle will lose energy traversing the medium
through interactions with electrons and nuclei within calculation volume. The si-
mulation applies the effects of interactions with a random number generator and
probability distributions for the various interaction types. The particle path of one
photon/electron within the patient geometry is followed until all energy is absorbed
above a minimum threshold or all secondary particles have left the specified geo-
metry [27]. The algorithm simulates the particle paths, called histories, for a very
large number of particles over the defined geometry.
Over the clinical energy range, photons transfer energy to electrons and posi-
trons via three types of interactions; Compton scattering with electrons, pair pro-
duction and photoelectric absorption. Electrons transfer energy through inelastic
collisions and radiative interactions. For inelastic collisions involving interaction of
the particle with a bound electron, secondary particles are produced, called delta
rays. Radiative interactions return energy to photons through positron annihilation
and Bremsstrahlung. Elastic collisions are defined by a modification in the direction
of propagation of the electron. Rather than model each interaction separately, elas-
tic collisions may be collapsed together into a single event with continuous energy
loss, known as condensed history simulation [27, 28]. The resulting radiation field
can be described by complex transport equations, for which Monte Carlo provides a
statistical solution method. The complexity of the equations necessitates significant
approximations for an analytical solution method.
The energy deposited in a unit volume, generally a voxel, is calculated by de-
termining the energy difference between the particles entering the volume and those
leaving. The energy per unit mass, or dose, is then calculated by summing the
contributions from all interaction events occurring within a voxel and dividing by
the mass of that volume [29].
Monte Carlo treatment planning systems use modified Monte Carlo codes, de-
signed specifically for the application of determining dose distributions within a
patient and associated fluence maps. General purpose codes such as GEANT4 for
radiation transport calculations are capable of simulating particles histories over a
very large range of energies, materials and geometries, much of which is superfluous
for linear accelerator modelling. Vendors hence use modified code, optimised speci-
fically for EBRT treatment planning, restricting parameters such as beam potential,
particle types and density range to those found within a clinical setting. Coupled
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with variance reduction technique, this significantly reduces calculation times.
This statistical calculation method is the most accurate treatment planning
system algorithm [27], able to accurately compute 3D dose distributions in very
complex physical geometries with heterogeneities. Monte Carlo is the ideal method
for calculating dose through or adjacent to lung tissue where large inhomogeneities
exist. Monte Carlo performs much better under these circumstances by directly
solving the transport equation without making any of the assumptions or simpli-
fications required by other TPS algorithms such as superposition-convolution and
pencil-beam techniques. The inherent disadvantage of this calculation method is
extensive computation times, taking significantly longer than other algorithms. A
complex VMAT technique may take as long as 1-2 hours to complete dose calculation
and segmentation.
2.3.2 The Monaco Treatment Planning System
The Elekta (Crawley, UK) Monaco treatment planning system utilises a Monte
Carlo based algorithm for both photon and electron calculations. The Monaco
photon algorithm, X-ray Voxel Monte Carlo (XVMC), is based on the original code
for electron dose calculations, Voxel Monte Carlo (VMC). The planning system uses
a virtual source model created from measured data to model the linac treatment
head rather than a full Monte Carlo simulation to improve calculation times. CT
image input is used to determine the patient geometry. The input voxel data is
converted to relative electron density and mass density for the patient model.
The algorithm is designed specifically for use in calculating radiotherapy treat-
ment doses and hence a series of variance reductions are used in the code to reduce
calculation times when compared to a more generalised Monte Carlo code. Vari-
ance reduction techniques used in the following the photon histories are interaction
forcing, electron history repetition and Russian Roulette [30]. The software also
places radiotherapy-specific limitations on the appropriate density ranges, uses a
finite beam energy range from 1 to 25 MeV and voxelised patient models. The
Monaco technical reference cites a confidence limit of 2.1 % for lung inhomogeneity
calculations based on a phantom with a balsa wood insert of electron density 0.2
and grid size of 3 mm [30].
2.4 Dosimetry
2.4.1 Ionisation Chambers
Ionisation chambers are the most common dose measurement tool used in radiother-
apy and are considered the gold standard for point dosimetry. Ionisation chambers
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consist of a gas-filled cavity (usually air) separating a positive and negative terminal.
Ionising radiation interacts with the air particles within the chamber, inducing ions.
Under an applied voltage, electrons or positively charged atoms will drift to the col-
lecting electrode. The charge collected is measured and displayed by an electrometer
and is proportional to the dose deposited in the gas medium. Ionisation chambers
are highly sensitive and have good stability with time and cumulative radiation.
Cylindrical (or thimble) chambers consist of a central electrode encased in a
cylindrical outer electrode with active volumes up to approximately 1 cm3. Cylin-
drical chambers are routinely used in megavoltage measurements for both absolute
and relative dosimetry. These chambers have specifically designed central electrode
lengths to minimise energy dependence, shortening the length to reduce the energy
and dose to water correction factors and uncertainties. A guard ring is also included
to reduce leakage. A polarising voltage is applied to the chamber to separate ion
pairs formed during irradiation, resulting in a net ionisation current measured by an
ammeter. The voltage should be high enough such that the recombination within
the chamber is suppressed to a negligible level and most ion pairs created contribute
to the current. At this equilibrium, ion saturation occurs and the current measu-
red by the ammeter is a constant, true representation of the rate of ionisation pair
production within the detector volume. The typical polarising voltage for ionisation
chambers is 300 V and at the Prince of Wales Hospital, standard practice is to use
central electrode positive (CEP). Under this condition, electrons are collected by the
positively charged central electrode and positive ions recombine at the wall, which
is earthed.
The number of ionisations in a medium is proportional to the dose deposited
within that medium, hence the charge collected by an ionisation chamber can be re-
lated via a series of correction factors to the absorbed dose. Correction factors must
be applied to correct the raw reading, MQ, for influence qualities as well as chamber
calibration and perturbation factors which convert the measured charge to absorbed
dose in water in the case of absolute dosimetry. For relative measurements, only
changes in measurement influence qualities need be considered. Factors correcting
for recombination and polarity can generally be ignored when a reference measure-
ment is taken with the same beam quality to be used for experimentation. Similarly,
an electrometer calibration factor is unnecessary provided the same electrometer is
used for all measurements. Finally however, a correction for ambient environmen-
tal conditions must be considered. Changes in ambient temperature and pressure
affect the volume of air inside the chamber cavity since it is unsealed, and hence
the total charge collected. To account for this, reference readings should be taken
before and after experimental measurements to determine any change in conditions.
Alternatively, the environmental conditions can be monitored using a thermometer
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Figure 2.3: Structure of GAFChromic EBT3 dosimetry film [33].
and barometer for any changes.
The IBA compact chamber CC04 is a thimble chamber and purposefully de-
signed for highly reproducible measurements in various media including solids, and
suitable for relative photon dosimetry. The CC04 chamber has a cavity volume of
0.04 cm3, cavity length 3.6 mm, and radius of 2.0 mm. This chamber is a fully
guarded, waterproof chamber with high uniform spatial resolution, making it suita-
ble for measurements in small fields and beams with high dose gradients, including
IMRT and SBRT techniques [31].
2.4.2 Gafchromic Film
Film dosimetry is a useful tool in radiation oncology for dosimetric analysis, par-
ticularly in obtaining two-dimensional dose distributions with areas of steep dose
gradients. Radiochromic film has the added advantages of requiring no chemical
development and having close tissue equivalence. These aspects, in addition to high
spatial resolution, near energy-independence over a specified range and achievable
accuracy of 4 % within a clinical environment, give radiochromic film frequent cli-
nical utilisation particularly for IMRT quality assurance [32].
Commercially available GAFChromic EBT3 (Ashland) is designed specifically
for applications with the optimal dose range 0.2 to 10 Gy. The structure of the film
consists of two layers of matte-polyester substrate encasing an active layer of marker
dye and stabilisers as shown in figure 2.3. Image development in radiochromic film
is the result of a dye-forming or polymerisation process, with yellow dye turning
blue after exposure to radiation in the case of EBRT3. Energy is transferred from
incident particles to the marker dye, causing a chemical change resulting in colour
formation [34]. The change in opacity I/I0 to optical light is related to the film
optical density by the logarithmic equation
d = log(I)/(I0) (2.1)
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where I0 is is the initial light intensity transmitted through the film and I is the
intensity transmitted through irradiated film in the direction perpendicular to the
plane. Calibration films are used to determine sensitometric curves to relate the
optical density at a point to the absorbed dose [34]. The manufacturers recommend





where dx(D) is the optical density of the film in scanner channel x for a dose
D, and equation parameters a, b and c are to be fitted. The rational nature of
the function necessitates only approximately 6-8 calibration points per case. This
includes an un-irradiated film (i.e. dose = 0 Gy) with doses increasing in geometric
progression to encompass the highest expected dose.
A 48-bit flatbed colour scanner such as an Epson Expression 11000XL Photo
scanner is recommended for use with EBT film [33]. These scanner types measure
the 3 colour components (red, green and blue) of the transmitted light at 16 bit per
channel, and have an extra large scanning bed useful in scanning both large pieces
of film, and multiple small films simultaneously with or without a template [33].
Analysis may be performed using a single dose channel (usually red for the 0.2 - 10
Gy dose range) or using multichannel dosimetry techniques.
EBT3 is suitable for use in IMRT dose verification, provided the handling and
processing recommendations are observed, particularly ensuring the film orientation
remains consistent [11, 35]. Patient IMRT fields can be recalculated onto a quality
assurance phantom and delivered to film placed at a known depth. The measured
dose distributions can be compared to the treatment planning system-calculated
dose distributions, most often using gamma analysis (defined in 2.4.3). This allows
the physicist to ascertain any differences between the planned and delivered doses,
and assist in determining both the accuracy of the planning system and the ability
of the linac to deliver the planned treatment fields.
2.4.3 Gamma Analysis
The quantitative analysis of dose distributions is achieved by directly comparing the
planned isodose distributions to the measured dose planes using gamma analysis.
Dose metrics are most applicable in regions of low dose-gradient, where the diffe-
rence between calculated and measured doses at a point are determined and have
a pass/fail criterion based on designated acceptance tolerances. In regions of high
dose gradient, a small geometric shift could result in a large dose disparity. Here
distance metrics are used to determine the distance between a measured dose point
and the nearest calculated data point with a matching dose, known as distance-to-
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Figure 2.4: Geometric representation of dose distribution evaluation criteria
with ellipsoid surface [36].
agreement (DTA). The gamma index is a numerical quality index that combines
both metric criteria, where the dose and distance differences have equivalent weig-
hting. The index provides a measure of the degree by which a region passes or fails
the acceptance criteria and can be conveniently displayed graphically.
The gamma index method can be summarised mathematically as follows [36].
DM is the dose-difference criterion (a value of 3 % is regularly used) and dM is
the DTA criterion (a value of 3 mm is regularly used) and are evaluated for a
single measurement point rm located at the origin of the geometric representation
(see figure 2.4). The x and y axes represent the spatial location of the calculated
distribution relative to the measured point rc. The vertical axis, δ, displays the
difference between the measured dose, Dm(rm), and calculated dose, Dc(rc). An
ellipsoid surface represents the acceptance criterion.









where r = |r - rm| and δ = D(r) - Dm(rm) is the dose difference at position rm.
If any part of the calculated distribution surface intersects the defined ellipsoid the
calculated point rm passes the criteria. This equation can be used to determine the
gamma index, γ, at each point in the evaluation plan rc-rm for the point rm hence
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And hence the pass/fail criteria can be defined by
γ ≤ 1, calculation passes
γ > 1, calculation fails
The advantages of gamma index methods are that they allow for a general
comparison that simultaneously considers dose differences and DTA, the γ values
can be displayed as an iso-distribution and the degree to which a point fails is known.
Modern software displays dose planes and highlights the locations of failed points
or regions, and indicates whether the calculated dose is lower or greater (colder or
hotter) than the measured dose. The quality of agreement of a beam can thus be
assessed on either the absolute number or percentage of points that pass the criteria.
Gamma analysis is the comparison metric used by the commercially available
Sun Nuclear Corporation SNC Patient software. This software is used throughout
this project to establish dosimetric differences between two dose planes. The depart-
ment’s version of software (version 6.2.3) uses an initial simplified approach, first
checking if the dose difference is less than or equal to the prescribed 3 % criteria,
and if this fails, checking if the nearest point on the calculated grid of the same
dose is within the prescibed 3 mm criteria. In this case, the point is considered a
passing detector point. In the event these simplified methods both fail to produce
a passing point, Low’s method described above is used to find a passing point of
the gamma value less than or equal to 1. If a gamma value is found to be greater
than 1, the detector point fails. This system focuses more on finding the number of
failing points, rather than the individual gamma values [37].
2.5 Phantom Materials
2.5.1 Solid Water
While reference dosimetry is defined as the dose to water, it is often more convenient
to perform reference measurements in a solid substitute for water. Water tanks are
generally very time consuming to set up. Additionally, only waterproof dosimeters
may be used. Solid Water (Gammex) is a commercially available water substitute
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for use in therapeutic radiotherapy beam qualities. According to the manufactu-
rers, Solid Water is designed specifically to scatter and absorb radiation with the
same characteristics as water over the clinical range of energies. This rigid substi-
tute exhibits excellent water equivalence at MV photon energies and allows depth
specification at millimetre intervals.
Solid Water slabs have a physical density and relative electron density very close
to water (see table 2.2). The material is made predominantly from carbon, oxygen
and hydrogen, with a high carbon component to give a solid structure at room
temperature while maintaining a similar effective atomic number. Kurudirek [38]
found the effective atomic numbers of water and Solid Water to differ by less than









Table 2.1: Elemental composition of Solid Water (% by weight) according to
manufacturers (Gammex).
Characteristics Solid Water Water
Physical Density 1.04 g/cm3 1.00 g/cm3
Effective Atomic Number 8.111 7.42
Electron Density 0.563xNA e
-/cm3 0.555xNA e
-/cm3
Electron Density Relative to Water 1.014 1.00
Table 2.2: Characteristics of Solid Water according to manufacturers (Gammex)
and water [39].
Material 6 MV 15 MV
Water 3.42 3.50
Solid Water 3.62 3.703
% Difference 5.52 5.48
Table 2.3: Effective atomic numbers of water and Solid Water for photon po-
tentials [38].
Solid Water is used as a substitute for water and tissue at several stages of
this project. Solid Water replaces water as the medium used to determine reference
ionisation chamber measurements in order to convert measured charge to dose. It is
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also used both in a slab phantom and custom made respiratory phantom to simulate
liver and surrounding tissue.
2.5.2 Cedar Wood
Cedar wood is used in the respiratory phantom to simulate lung tissue which has a
significantly lower physical and electron density than normal tissue. The low-density
cedar used has a relative electron density of approximately 0.4. This material was
chosen both for density properties and practical reasons including low cost, easy
to machine to custom shapes and robustness which allowed the wood to undergo
motion within a Perspex casing and disassembly and reassembly without any phy-
sical deformation. Cedar wood is currently used in commercial phantoms for lung





An in-house phantom was designed by the author and Mr Simon Downes specifically
for use in the project but with the aim for further application in future projects. The
primary design criteria were to replicate the lung-liver interface of an adult patient
using tissue-equivalent materials and to simulate respiratory motion in the superior-
inferior direction. Studies show [23] that the largest movement of liver tumours is in
this direction and caused predominantly by respiration. The motion was designed to
emulate a standard non-sinusoidal breathing pattern, with the average person spen-
ding approximately 70% of a breathing phase in inhalation [40]. It was preferable
that the breathing rate and amplitude could be adjusted as necessary, to assess the
impact of these parameters on the fractional dose distrbution and interplay effect.
The phantom also needed to hold various dosimeters with minimal air gaps. After
consideration of the possible detectors to be used, EBT3 film and a CC04 ionisation
chamber were selected. The film would be used to obtain high-spatial resolution
2-dimensional dose profiles and was suitable for the energy and total doses to be
delivered. The small width of the film (approximately 0.3 mm) allows the film pieces
to be slotted into several depths of the phantom with no milling required. Ionisa-
tion chambers remain the gold standard for point dose measurements and the CC04
chamber volume of 0.04 cm3 gives an adequate point dose approximation with the
additional benefit of instant read-out.
The phantom was to be constructed of materials already purchased by the Ra-
diation Oncology Department to assist in cost savings and allow construction to
begin immediately following the design process. Robustness was important to en-
sure the phantom could withstand many measurements under motion, as well as
22
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Figure 3.1: Phantom schematics showing; A. Coronal view, B. Sagittal view
and C. Transverse view, with lung material (yellow), liver material (gray) and
location of the cam drive and motor (left). Units in mm.
withstand constant dis-assembly necessary to replace the film. Flexibility in design
was also desired to allow the phantom to be used in future applications and research.
The phantom was constructed within the department by the employed mechanical
craftsman.
3.2 Construction
The phantom was constructed by the Radiation Oncology workshop at the Prince
of Wales Hospital. A schematic diagram of the phantom can be seen in figure 3.1
The phantom consists of two adjacent slabs of materials representing the lung and
liver respectively, each sliced into 4 separable sections to allow film placement at
various depths in the coronal plane. The lung slab has dimensions 19 cm (left-right)
by 7 cm (superior-inferior) by 10 cm (anterior-posterior) and is constructed from
cedar wood. The liver slab is comprised of Solid Water and has an additional 3 cm
length in the superior-inferior direction. Each section is held together by vertical
plastic rods. Three metal spheres of diameter 5 mm were placed in the liver slab
to act as surgical clips for image registration. The slab was encased in Perspex to
provide build up and simulate the thoracic walls, with open ends to accommodate
respiratory motion.
A cam drive system was installed to drive the respiratory motion, with the
cam shaft attached to the lung slab and an electric motor used to rotate the cam.
Adjustable speed settings allows for a range of ”breathing” rates while the cam
CHAPTER 3. PHANTOM DESIGN AND COMMISSIONING 24
Figure 3.2: Custom-made lung-liver respiratory phantom, deisgned and con-
structed by the Prince of Wales Hospital Radiation Oncology Department.
provides a motion amplitude of 1.3 cm, resulting in a total displacement of 2.6 cm.
A 2 cm by 2 cm slot extending out of the liver slab was created to insert a CC04
holder of the same material. The cavity places the ion chamber effective point of
measurement 1 cm from the lung-liver interface and a central depth of 7 cm. The
slot is filled with Solid Water pieces when a chamber is not in use.
A Perspex platform was mounted on the base and connected to the cam drive
system such that it moves vertically complimentary to the horizontal motion of the
phantom. The platform provides a means for the CT scanner to track and record
(histogram) the motion using Varian Real-time Position Management (RPM) 4-D
tracking system. The small, marked tracking box is mounted on the platform, and
tracked by the RPM infrared camera. The RPM system monitors the frequency and
amplitude of the tracking box motion, replicating the respiratory cycle. This infor-
mation is fed directly into the CT controls during a 4D acquisition to accurately bin
the acquired slices into the correct phase space. Figures 3.2 and 3.3 are photographs
of the finished phantoms showing the full phantom and the location of the detectors
respectively.
3.3 Design changes
Following commissioning of the system there were several modifications made to
the phantom. During initial 4DCT scans, it was found the reflection of the 4D
marker box from the Perspex phantom surface was causing interference with the
phase acquisition. A piece of blank paper was taped to the top Perspex surface of
the phantom to prevent reflection interfering with the infrared signal. After several
minutes of phantom motion, it was apparent the spring used was not strong enough
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Figure 3.3: Location of detector inserts for lung-liver respiratory phantom.
to return the full weight of the lung/liver slabs to the original position, thus reducing
the amplitude of motion. The spring was replaced with a more robust model and
amplitude reproducibility was re-tested for several breathing rates. The slab was
found to retain the amplitude to within 1 mm, however it was surmised that frequent
testing was pertinent and the spring was to be replaced as necessary.
Upon examining the CT reconstruction is was also found that the ball bearings
inserted for localisation caused a significant streaking artefact into the surrounding
liver medium. After discussions with the gastro-intestinal radiation oncology speci-
alist it was determined the balls used were significantly larger than the surgical clips
routinely used for patients. As a result, the balls were replaced with smaller balls of
2 mm diameter. The excess gap in the liver material was filled with resin to reduce
air gaps. The phantom was then re-imaged using the same scanning parameters,
and while the artefact was still present, the streaking had been significantly reduced
and was on par with patient scans using surgical clips. The observed difference can
be seen in figure 3.4.
It was also noted that in order to place a film within the phantom, the entire slab
must be disassembled and removed from the Perspex casing. This requires the drive
mechanism to be separated from the slab assembly, reducing the motion amplitude
reproducibility. This method would also be very time consuming given the total
number of films to be scanned. Thus the phantom construction was modified such
that the Perspex top was removable, allowing easy access to the film plane and
removing the need to disconnect the drive mechanism. This modification reduced
the time to change a film down to approximately 1 minute.
Marks were placed on the exterior of the Perspex to align the phantom to the
lasers in the linac treatment room before CBCT was used for fine adjustments before
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Figure 3.4: Comparison of the streaking artefact by the initial ball bearings
of 5 mm diameter (top) and the replacement ball bearings of 2 mm diameter
(bottom).
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placement of the dosimeters.
3.4 Commissioning and Validation
Prior to using the phantom for research dosimetry, several commissioning processes
were undertaken to verify the reproducibility, accuracy and usability of the phantom.
Simple adjustments of the voltage were needed to adjust the motion speed and the
markings on the phantom allow efficient set up in the treatment room. Adjustments
to the Perspex case allowed simple access to the inner materials to insert and remove
Gafchromic film.
An initial CT scan of the construction materials was conducted prior to the
assembly of the phantom to ensure the cedar and Solid Water represented a typical
lung and liver respectively with a reasonable degree of accuracy. The relative elec-
tron density of the Solid Water to water was measured to be 0.97 by the Monaco
planning system and the cedar wood lung material averaged 0.40. The Perspex
casing was determined to be 1.07. An investigation into corresponding body tissue
measured on the same planning system found the liver relative electron density of a
patient to range from 1.03 - 1.06 and lung density to range from 0.15 to 0.3.
The movement of the phantom was re-assessed after replacement of the spring
and found to be 2.6 cm and reproducible to within 1 mm. The displacement of the
materials was measured between the static inhale and exhale measurements for each
set of measurements. The time for one complete cycle was set prior to each motion
measurement and was measured for at least 4 individual cycles using a stopwatch.




The human body is comprised of many tissue types with a wide variation of mass
and electron densities. Regions of the body where high differences of electron den-
sity are adjacent to each other add an additional level of complexity to radiotherapy
treatments than those comprised of mostly water equivalent materials. Heteroge-
neities such as the area within the body where the low density lung meets the
water-equivalent liver tissue are generally poorly modelled by treatment planning
systems due to the change in scattering behaviour of the transient particles.
A simple experiment was designed to determine the reduction in dose deposi-
ted to a water-equivalent medium in a megavoltage radiation field if the adjacent
medium was replaced with one of a much lower density. The aim was to establish
whether the reduction in lateral scatter to the point of measurement was significant
in the total dose delivered at the point and how this affect changes with field size,
depth and distance from the heterogeneity interface.
4.2 Methods
Two simple block phantoms were used to carry out the experimentation on an Elekta
Axesse linac. In the first case, a phantom made from two large blocks of Solid Water
was used to simulate the case of normal tissue under full scatter conditions. The
interface of the blocks was placed on central axis and 5 cm of Perspex was used
as backscatter material at the base. For the second case, one block of Solid Water
was removed and replaced with a block consisting of 2.4 cm of Solid Water at the
top to simulate the chest wall, a set amount of cork, dependent on the depth of
measurement, to simulate the lung and 5 cm of Perspex for additional backscatter
and to represent the posterior chest wall. The interface between the two blocks
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Figure 4.1: Block phantoms used for point dose measurements; A. Solid Water
block phantom for full scatter conditions, B. Solid Water section replaced with
cork insert to simulate lung/liver interface. Units shown in cm.
remained on central axis and acted as a representation of the lung-liver interface
located within the human thoracic cavity. Cork was used in this experimentation
due to the availability of large, 1 cm thick slabs in the department from a previous
project.
A CC04 ionisation chamber (serial number 12856) was placed in a chamber
holder and inserted into the Solid Water block phantom, with measurements taken
at depths of 5 cm and 15 cm. Square field sizes of 5 cm x 5 cm, 10 cm x 10 cm,
and 15 cm x 15 cm were used for each depth. The chamber was placed on the
central Y-axis and placed at distances of 1 cm, 2 cm, 3 cm and 5 cm from central
axis in the X direction (gun-target orientation on linac), within the specified field
sizes. Pieces of Solid Water were inserted between the interface and the chamber
holder as the chamber was moved laterally to maintain the Solid Water phantom as
shown in figure 4.1. The chamber was aligned using the collimator crosshairs and a
source-axis distance (SAD) of 100 cm was set using the wall-mounted lasers, taking
into account the effective point of measurement of the CC04 chamber. A Fluke
Biomedical 35040 Therapy Dosimeter electrometer (serial number F040C) was used
to obtain charge readings, with each beam delivering 200 MU at 10 MV. Although
the linacs also have 6 MV capabilities, it was decided to use 10 MV only, as this
was the most likely selection for abdominal treatments and 6 MV VMAT had not
yet been released for clinical use within the department.
For the 5 cm depth measurements the Solid Water block consisted of 12 cm of
Solid Water, with a 5 cm base of Perspex. The lung block consisted of 2.4 cm of
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Solid Water at the top, followed by 9.6 cm of cork and the Perspex base. For the 15
cm depth measurements the Solid Water block consisted of 16 cm of Solid Water,
followed by the Perspex base and the lung block consisted of 2.4 cm of Solid Water
atop, 13.6 cm of cork, followed by the Perspex base.
4.3 Results
At 5 cm depth, the maximum difference between the Solid Water phantom and the
cork phantom measurements was 1.06 %. For each field size, the highest difference
was seen at the point closest to the interface (distance of 1 cm). In addition, the
differences exhibited for a given distance from the interface increased with increasing
field size. The results at 5 cm depth are displayed in table 4.1.
There was a significantly higher difference between the doses measured in the
Solid Water phantom and cork phantom at a depth of 15 cm than for 5 cm under
the same set up conditions. The highest difference recorded was 3.6 %, also for
a 15 cm x 15 cm field size at 1 cm from the interface. Consistent with the 5 cm
depth results, the differences increased with field size and were higher closer to the
interface. The results for the 15 cm depth measurements can be seen in table 4.2.
Field Size Distance from Interface Average Reading (nC) Difference
cm2 cm Solid Water Cork %
5 1 2.072 2.061 0.53
2 1.978 1.979 -0.05
10 1 2.197 2.179 0.84
2 2.205 2.196 0.43
3 2.195 2.187 0.36
15 1 2.266 2.242 1.06
3 2.275 2.263 0.53
5 2.264 2.261 0.15
Table 4.1: Comparison of point dose measurements in the full Solid Water
phantom and with the cork insert at 5 cm depth.
4.4 Discussion
The results show that a lack of lateral scatter can have a significant impact on the
dose delivered in a medium, particularly at larger treatment depths. This implies
that accurate dose modelling is required not only for treatment fields passing directly
through regions of low density but also when fields are angled parallel to an inhomo-
geneous interface. There appears to be a clear correlation between the magnitude
of the dose reduction and distance from the interface the size of the treatment field.
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Field Size Distance from Interface Average Reading (nC) Difference
cm2 cm Solid Water Cork %
5 1 1.497 1.462 2.36
2 1.365 1.353 0.85
10 1 1.656 1.606 3.01
2 1.651 1.617 2.09
3 1.629 1.606 1.42
15 1 1.750 1.687 3.61
3 1.743 1.713 1.76
5 1.706 1.691 0.88
Table 4.2: Comparison of point dose measurements in the full Solid Water
phantom and with the cork insert at 15 cm depth.
This experiment suggests that in the case of liver tumours, the dose reduction effect
from the low density lung tissue will be most relevant for deep-seated tumours close
to the superior liver borders. The effect will also be larger for fields that extend




3D conformal is one of the two techniques currently used within the Prince of Wales
Hospital Radiation Oncology department to treat 4D SBRT cases, for both lung
and liver sites. Gating techniques are not currently possible within the centre.
To compensate for the motion of a tumour within the thoracic region, respiratory
management and planning techniques must be employed to ensure the tumour target
receives the prescribed dose. The current practise within the department is to
acquire a 4D planning CT, while monitoring the patient’s breathing rate using the
Varian RPM system and the patient’s breathing volume using Elekta’s ABC system.
The clinical target volume (CTV) is contoured on each of the 10 phases obtained by
the CT scanner and summed with a margin added to create a planning target volume
(PTV). Plans are then calculated on the exhale phase. The patient’s expiration
volume is monitored during treatment and if it exceeds the specified threshold, the
beam it interrupted. In this way the tumour moves only within the PTV field during
beam-on time, as shown in figure 5.1.
Due to the large PTV size compared to the actual tumour volume, conformal
techniques have long been employed as a simple method to create coverage of the
PTV. The delivered dose distribution becomes distorted due to motion when com-
pared to the calculated dose. The conformal technique has been experimentally
verified to deliver the full prescribed dose to target even under respiratory motion
conditions. There is however an excess of dose delivered to the surrounding tissue
and spreading of the penumbra in the direction of motion.
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Figure 5.1: Movement of the anatomy and CTV (red) within the treatment
field in the exhale position (A) and inhale position (B).
5.2 Methods
5.2.1 Simulation and Planning
A 4DCT data set was acquired on the Toshiba Aquilion LB scanner located within
the radiation oncology department for planning. The phantom was aligned using
the CT external and internal lasers to the marks placed previously on the phantom
which indicated the intended isocentre. The phantom was aligned such that the
’patient position’ was supine, head-first orientation, which is the standard patient
set up for this treatment technique. Prior to scanning, a patient was created both
in the Toshiba CT scanning system and the department’s oncology information and
record and verify system, Mosaiq, with identical credentials. A preliminary scan was
taken to ensure the phantom was aligned parallel to the couch and to define the scan
limits in the superior-inferior direction. Care was taken to include the full length of
the phantom to define an external contour, however no more slices than necessary
were taken to reduce the size of the data set as much as possible. The standard
retrospective imaging protocol for 4D treatments was used with a slice thickness of
3 mm.
A data set was acquired for breathing rates of 8, 14 and 23 breaths per minute
(BPM), as well as a standard 3D data set with phantom fixed in the exhale phase.
A Varian RPM 4D tracking system was used to track the motion of the phantom
and communicate with the CT scanner to bin images into 10 phases. This was
achieved with a tracking box with infra-red markers was placed on the vertically
moving platform, which is tracked by the RPM infra-red camera mounted to the
end of the CT couch.
Each data set was exported individually to the pre-planning workstation, Mo-
nacoSim (Elekta), in order to identify different study sets. A maximum intensity
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projection (MIP) and average image were created for each image set and analysed
for differences. It was found that there were no differences in the study sets due
to differences in breathing rates hence the study sets for 8 bpm and 23 bpm were
deleted from the patient file and motion plans were all created on the 14 bpm study
set. This decision created the advantage of reduced planning time, lower likelihood
of exporting incorrect images and beams and making the patient data size more
manageable. The MonacoSim program was then used, under the guidance of an ex-
perienced planning therapist, to contour the phantom in the exhale position as per
departmental protocol for 4D patients. The exhale phase is used for this purpose as
it is the only image phase available on both the Monaco planning system and the
Elekta linac kV imaging system (XVI). Similarly, processed images such as MIPs
are cannot be used for this purpose. The isocentre is thus placed on in the exhale
phase, while the PTV is generated by summing the CTV contour on each phase and
adding additional margins.
Edge detection was used to contour each of the three ball bearings and the
resultant artefacts. The artefact contour was force-filled to an electron density of 1,
and the extended CT to ED file was selected. This ensures the selected medium is
not erroneously assigned a different density due to the artifact caused by the heavy
metal ball bearing. An auto-thresholding tool was used to contour the ’skin’ (patient
contour), the ’lung’ and the ’liver’. The standard department template was used to
add in the couch contour which was combined with the patient contour to produce
the final external contour required by the Monaco TPS.
As there was no defined tumour in the phantom, a simple PTV was created
on the data set, based on tumour statistics or previous patients, the size of the
ionisation chamber, expansion margins and respiratory motion. Planning data was
extracted from the department archives for 8 previous patients who had been treated
using SBRT 4D IGRT for primary or metastatic liver lesions, 3 patients of which
had two lesions. Details of the lesion sizes and planning parameters can be found
in table 5.1.
The average PTV volume of the lesions listed in the table above is 183 cm3, with
a median of 60 cm3. Removing the two largest volumes which may be considered
outliers, gives an average volume of 80 cm3 and this was the selected volume chosen
for the plans. The shape of the ITV was decided to approximate a spherical clinical
tumour volume lengthened in the superior-inferior plane due to respiratory motion,
giving a capsule shape. An expansion of 6 mm was applied under the direction
of the radiation oncologist responsible for the majority of SBRT liver treatments
within the department to generate the PTV. The PTV was positioned such that
theoretical CTV appears very close to the superior liver border, and hence the PTV
extends several millimetres into the lung material. The PTV contour was created
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Patient Lesion PTV Volume Mean Dose to Presc. Dose Beam Potential
(cc) Target (cGy) (cGy) (MV)
1 1 281.6 5233 4800 10
2 1 832.73 3295 3500 10
3 1 59.92 5337 4800 10
4 1 52.26 3908 3500 10
5 1 132.5 4545 4200 10
6 1 27.4 4184 4000 10
6 2 17.03 4397 4000 6 and 10
7 1 49.36 4059 4000 6 and 10
7 2 34.7 4090 4000 6 and 10
8 1 65.3 4484 4000 10
8 2 457.8 4514 4000 10
Table 5.1: PTV and plan data from previous SBRT liver patients at POWH.
Figure 5.2: CT coronal view of the PTV contour (red) and OAR 1 (pink).
using a rectangular 2D contour of width 0.09 cm and length 2.6 cm, (displacement
of phantom motion) and adding a 3D uniform expansion of 2.25 cm giving a capsule
of total volume 94.6 cm3. This structure was sufficient to enclose the ionisation
chamber volume.
Two generic organs at risk volumes were also created adjacent to the PTV to
force modulation within the plans and more accurately replicate a clinical plan.
OAR 1 had a total volume of 25.97 cm3 and was located to the right of the PTV,
while OAR 2 had a volume of 17.70 cm3 and was positioned posteriorly to the PTV
as seen in figures 5.2, 5.3 and 5.4, representing the spinal cord. The completed
contoured study set was used to plan each of the three treatment techniques.
Upon completion of contouring, the study set was exported to the Monaco TPS
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Figure 5.3: CT transverse view of the PTV contour (red), OAR 1 (pink) and
OAR 2 (purple).
Figure 5.4: 3D view of the PTV contour (red), OAR 1 (pink) and OAR 2
(purple).
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for planning. The prescription was taken from the accumulated patient data and
reflected current practise and was defined to be 4000 cGy in 5 fractions, resulting
in a fractional dose of 800 cGy. A beam potential of 10 MV was selected from the
available options of 6 MV and 10 MV due to the depth of treatment with a 6-beam
isocentric arrangement chosen for delivery speed and to avoid critical structures.
The fields were equally weighted and focused in the anterior and left directions to
avoid the OAR structures. The plan was calculated using the Monte Carlo algorithm
with a grid spacing of 0.2 cm, with dose prescribed to isocentre. While the resultant
plan had sub-optimal coverage of the PTV on the right side due to OAR 1, the plan
was deemed acceptable for the verification purposes of this project.
The complete plan, including beams, prescription and structure sets was ex-
ported to the record and verify system. The reference image set was sent to the
Axesse Elekta linac, kV imaging system (XVI) for alignment purposes. While the
linac has couch rotational abilities through the Hexapod system, the tracking frame
cannot currently be used with 4D patients due to space limitations. Therefore, only
translational corrections were enabled for set up corrections. The fractional point
doses and dose profiles were exported from the planning system for comparison to
the measured doses.
5.2.2 Ionisation Chamber Measurements
The point dose measurements were performed using an IBA CC04 ionisation cham-
ber in an appropriate insert. Prior to taking phantom measurements, a set of refe-
rence readings were taken under the department’s reference conditions to convert the
electrometer reading to absorbed dose. The CC04 chamber was used in conjunction
with a PTW electrometer. The readings were taken in a Solid Water phantom with
10 cm of backscatter to provide full scatter conditions. The readings were taken for
a delivery of 100 monitor units (MU) at an effective depth of 2.2 cm (the dmax for
10MV beam), with a 10 cm x 10 cm field size and source-surface distance (SSD)
of 100 cm. Under these conditions 100 MU is equal to a dose of 100 cGy at dmax.
The readings were recorded and the average charge reading was taken to be equi-
valent to 100 cGy (see results section). The reference readings were re-taken after
the phantom measurements to account for any changes to temperature, pressure or
machine output.
The phantom was then set up on the treatment couch and aligned to the laser
markers in the exhale position with the Solid Water pieces filling the chamber cavity.
The CBCT was taken with the parameters described in the section above. The
image registration was set to include the liver and external sections of the phantom.
Automatic grayscale registration was enabled and the two images were visually
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inspected to ensure the edges and ball bearings were aligned. Table moves greater
than the minimum couch movement for the Precise Table were enacted. The Solid
Water pieces were then removed from the cavity and the CC04 holder and chamber
were inserted. After ensuring they were flush, the chamber was taped into place
to prevent movement of the chamber with respect to the liver material while the
phantom was in motion. The same chamber and electrometer were used as those
used for the reference measurements.
Measurements were taken at isocentre, at a depth of 7 cm and distance 2 cm
from the lung-liver interface. A reading was taken for each beam for the static case
and the three pre-determined breathing rates of 8, 14 and 23 bpm. For each case,
a measurement was taken when the phantom was at the inhale phase during beam-
on and the exhale phase during beam-on. These raw readings were divided by the
reference reading in order to obtain the point dose in each case. The measured dose
was compared to the expected dose as calculated by the TPS for the same point.
Repetition of measurements with the phantom in the static position were used
to determine an average uncertainty in the ionisation chamber measurements of 0.20
%.
5.2.3 Gafchromic Film Measurements
Gafchromic EBT3 model 1417 film was used to measure 2D profiles for the treatment
fields. Film preparation was undertaken prior to measurements according to the
departmental procedure in order to get the most accurate and reproducible results
possible. A template was created from plain paper to ascertain the film size required
to both include as much of the treatment field as possible, and fit securely into the
phantom, covering both the lung and liver materials. From the template, a size of
10.3 cm x 14.0 cm was determined. Films of this size were cut with the orientation
maintained. Ten 5 cm x 5 cm films were also cut for calibration measurements. All
films used in this project came from the same batch number of 06261502 with an
expiry date of August, 2017 and the temperature indicator checked to ensure the
film had not been exposed to high temperatures during transit.
Each film was pre-scanned, flat on the glass of a film-dedicated EPSON Ex-
pression 10000XL scanner using a custom, black cardboard template affixed to the
glass, to ensure positional reproducibility and reduce excess light contributions from
areas outside the region of interest (ROI). SilverFast software was used to complete
the scans with the following parameters set; 48 bit HDR colour, 75 dpi, and no
automatic image adjustment. Five scans were taken and discarded to warm up the
scanner, and a pre-scan was used to create an ROI enclosing the films. This ROI
was maintained from the pre-scans through to post-scans. Each of the phantom
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films were scanned individually, while all 8 calibration films were scanned at the
same time within a single ROI. Each film was scanned 3 times.
The calibration films were exposed on the Axesse linac immediately prior to
the exposure of the treatment field films. The films were placed at dmax for 10
MV (2.2 cm) in Solid Water with 10 cm of Solid Water backscatter. A field size
of 10 cm x 10 cm was used with SSD 100 cm, hence the reference conditions of
the department were satisfied and number of monitor units delivered was equivalent
to dose. The pieces of Solid Water to come in direct contact with films were first
cleaned with chlorhexidine disinfectant solution and thoroughly dried to prevent
any contamination of the films. A film was exposed in the centre of the field for 0,
100, 200, 350, 500, 650, 800 and 950 MU/cGy in order to obtain a calibration curve
from which the dose to treatment films would be derived. The values were taken
to envelope the maximum and minimum expected doses output by the TPS, and to
have enough points to create a smooth curve.
The phantom was then placed on the couch, initially with no film in place and
with the Solid Water pieces inserted into the chamber cavity. A CBCT, as described
in the ionisation chamber measurements section, was performed and the Precise
Table moved accordingly. The alignment of the phantom markers was checked after
each change in film to ensure the phantom was not shifted during dis-assembly. In
the event the phantom was shifted the CBCT was acquired again to realign the
phantom. A single film was then placed within the phantom and isocentre marked
on each edge using the linac crosshairs projection, with the orientation always the
same; the marked corner of film was aligned to the ’patient’ right upper corner
assuming supine, head-first positioning. The film was located at depth 8 cm, 1 cm
below the centre of the chamber cavity, but well within the PTV plane. A film was
then exposed starting in the exhale position and starting in the inhale position for
the static cases and each of the three breathing rates, with a total of 8 films.
5.2.4 Gafchromic film processing
The films were left for longer than 24 hours to allow complete development of the
film and significantly reduce the error caused by the delay between exposing the
calibration films and treatment films from the decreased rate of polymerisation.
Each film was then post-scanned using the same method as the pre-scan and placed
in the same position on the scanner. The three scans for each film were averaged
and transformed to the orientation of the TPS exported dose planes. The corrected
images were then analysed using an in-house, python based film analysis program.
All film analysis was based on the red channel only. A calibration project was
created first. A 10 mm x 10 mm range of interest was created on the centre of
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each pre-scan and post-scan film image. A sigma value was assigned to each ROI
indicating the standard deviation across the range, and is used to assess all films in
which a gradient is not expected, i.e. pre-scans and calibration post-scans. A high
sigma value may be indicative of contamination of the light intensity such as texta
marks or specks of dust on the film. In this case, the ROI may need to be adjusted
or the film rescanned. The averaged opacity of the ROI for a pre-scan (unexposed)
image was found and the averaged opacity of the ROI of the corresponding post-scan
(exposed) film was found and the net optical density was obtained using equation
2.1. The optical density for each film was then associated with the corresponding
delivered dose to create a calibration curve for films measured on the Axesse machine
within the same batch.
The optical density of the treatment film scans was obtained in the same way,
however the post-scan ROI was made large enough to contain the entire film. The
aforementioned calibration file was used to map the calculated optical density to
dose in cGy. The program was then used to generate dose planes for each treatment
films in various formats. There are small regions of low opacity due to markings on
the edges of the film.
Dose planes were compared using Sun Nuclear Corporation’s SNC Patient soft-
ware to perform a global gamma analysis using 3 %, 3 mm criterion, with a threshold
of 10 %. A dose plane comparison was performed between the inhale and exhale
films for each breathing rate, an inter-comparison between the different breathing
rates as well as a comparison between the measured planes and those calculated
by Monaco. The film measured with the phantom in the static exhale position
represents the planning conditions and hence should result in the best match.
1D dose profiles were created in the superior-inferior direction through the lateral
isocentric position. The film dose profiles were converted to millimetere intervals
using the scanner pixel resolution (75 dpi) and smoothed using a 5 point moving
average in Microsoft Excel. Graphs were generated from the data for comparison
using Origin8 software, showing the measured dose versus location in the superior-
inferior plane. The location of the lung, liver and theoretical CTV are also shown
on the graph to demonstrate the coverage of the CTV and the dose to organs.
5.3 Results
5.3.1 Point Dose Measurements
Ionisation chamber readings were taken for each individual field for the static case
and 3 different breathing rates. For each case, measurements were taken with beam-
on while the phantom was in the exhale phase, and beam on when the phantom
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reached inhale. It should be noted that the accuracy of the beam-on point was
reduced with increasing breathing rate. The raw charge readings were converted to
dose by dividing the average reading by the average reference readings taken under
department reference conditions described above. Reference readings were taken at
the start and finish of the phantom experimentation and found to change by less
than 0.1 %. The average reference reading was 1.065 nC.
The cumulative dose for one delivered fraction was determined by the addition
of doses from each individual field, for each case and is documented in table 5.2. As
expected, the smallest difference occurs when the phantom is in the static exhale
position, which best represents planned conditions. Under motion, the difference
between the Monaco calculated dose as isocentre to the measured doses ranges from
-0.3 % to -0.5 %. This demonstrates that under motion, the isocontric position
received slightly less dose than the phantom at rest in the exhale position.
BPM Start Position Measured Dose Calculated Dose Difference
(Gy) (Gy) %
Static Exhale 7.321 7.317 0.1
Static Inhale 6.960 7.317 1.0
14 Exhale 7.292 7.317 -0.3
14 Inhale 7.280 7.317 -0.5
23 Exhale 7.287 7.317 -0.4
23 Inhale 7.292 7.317 -0.3
8 Exhale 7.292 7.317 -0.3
8 Inhale 7.294 7.317 -0.3
Table 5.2: Comparison of Monaco calculated point dose and results measured
with ionisation chamber for 3DCRT.
The doses for each field, averaged for each case are shown in table 5.3. On
average, the beam that showed the greatest difference was field 2, a left posterior
oblique field with gantry angle of 120o. For this field, the radiation beam enters the
phantom from an angle of 30o below horizontal, and passing through the maximum
amount of build-up material and thus have the highest component of scatter. The
field showed an average difference across all cases of -2.3 % and was consistent for
all respiratory rates and starting phases.
5.3.2 Film Measurements
The film-measured dose planes and the Monaco calculated dose plane were compa-
red. The global gamma analysis pass rate is determined by the percentage of the
total number of assessed points satisfying the 3 % 3 mm criterion, and above the 10
% threshold. The comparison results are displayed in table 5.4
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Field Number Gantry Angle Measured Dose Calculated Dose Difference
(o ) (Gy) (Gy) %
1 150 1.180 1.178 0.1
2 120 1.363 1.394 -2.3
3 90 0.815 0.82 -0.7
4 60 1.288 1.293 -0.4
5 30 1.357 1.357 -0.0
6 330 1.299 1.275 1.8
Table 5.3: Comparison of Monaco calculated point doses for each field, and
average measured result for all breathing rates.
Plane 1 Plane 2 Pass rate (%)
Calculated Static Exhale Measurement 97.6
Calculated 8 bpm Exhale Measurement 32.7
Calculated 14 bpm Exhale Measurement 41.1
Calculated 23 bpm Exhale Measurement 31.5
8 bpm Inhale Measurement 8 bpm Exhale Measurement 98.5
14 bpm Inhale Measurement 14 bpm Exhale Measurement 94.1
23 bpm Inhale Measurement 23 bpm Exhale Measurement 99.4
14 bpm Exhale Measurement 8 bpm Exhale Measurement 99.8
14 bpm Exhale Measurement 23 bpm Exhale Measurement 99.6
Table 5.4: Comparison of both Monaco calculated dose plane, and film-measured
dose planes using gamma analysis.
The comparison between the Monaco calculated dose plane and the static exhale
measurement film resulted in a pass rate of 97.6 %. The pass rate is expected to
be high as the planned conditions precisely match the measurement conditions.
There is significant increase in the number of points failing the gamma pass criteria
when the phantom is put in motion. The pass rate ranges from 31.5 to 41.1 %
for the different breathing rates. The measured planes show a dose spread of an
additional, approximate 2 cm in the superior direction for the motion cases. The
failed points were predominantly located in the superior and inferior borders. The
measured doses in the superior region were much higher than calculated and the
measured doses in the inferior regions were much lower than calulated. This reflects
the expected results, given that as the phantom moves to the inhale position the
lung and liver move inferiorly. This causes the upper region of the liver and the lung
to move into to the field and the lower lung region to move temporarily out of the
field (see figure 5.1).
The dosimetric differences between the measured films for a given breathing rate
when the beam was initiated while the phantom was in the exhale position, versus
the inhale position were also determined. This assists in determining whether the
point in the respiration cycle when the radiation beam is initiated has a significant
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Figure 5.5: 1D comparison between the planned dose profile and measured
profile with the phantom in a static, exhale position.
Figure 5.6: 1D comparison between the two static phantom position measured
profiles, in the exhale position (planned) and the inhale position.
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Figure 5.7: 1D comparison between the measured profiles for each breathing
rate, starting in the exhale phase.
Figure 5.8: 1D comparison between the planned profile and measured 14 bpm
profiles with the phantom starting on the exhale and inhale phase.
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impact on the dose distribution. The 14 bpm rate yielded the lowest result with a
pass rate of 94.1 %, while the 23 bpm rate had a percentage pass value of 99.4.
Finally, the measured films beginning in the exhale phase were compared for
each of the three motion cases to ascertain the effect, if any, the rate of respiration
has on the measured dose distribution. There was very little difference between the
measured dose distribution with a minimum pass percentage of 99.6 %.
1D profiles were taken from each dose plane in the superior-inferior direction at
the lateral isocentric points. The 1D profiles were analysed and plotted on a graph,
visually demonstrating the lung-liver interface and the CTV location. The graphs
demonstrate both the regions of deviation between different dose profiles and the
dose coverage to the CTV.
Figure 5.5 shows a comparison between the calculated dose and the measured
dose under the planning conditions, with the phantom in the exhale position without
motion. The graph shows good agreement between the two profiles, with a slight
increase in the measured dose in the umbra region. Figure 5.6 shows the profiles
for the two static cases, inhale and exhale. The graph shows the CTV coverage is
inadequate in the inferior region when the phantom is in the static inhale position,
with an increased dose of approximately 45 cGy delivered to the lower lung per
fraction. However, figure 5.7 establishes that, under motion, and regardless of the
rate of respiration the CTV receives the expected dose. The inferior penumbra
region lies 4 mm from the CTV edge. Combined with graph 5.8 we see that the
coverage is reproducible when changing both the breathing rate and point in the
cycle of beam-on, however the lower lung dose is higher than predicted by the TPS.
5.4 Discussion
The point dose measurements showed very little deviation between the calculated
dose and all measured doses. As the conformal fields are relatively large, open
fields with no intensity modulation, we expect little change due to movement in
the central region of the field. The measured fields received slightly lower dose
than anticipated at a depth of 7 cm with a distance of 2 cm from the heterogeneity
interface, with discrepancies similar to those measured in the static experimentation
for a depth of 5 cm. The under-dosing is most likely due to the lack of lateral scatter
contribution from the lung material, however the magnitude is approaching the size
of the measurement uncertainty. In all cases, the deviation from prescribed doses
was well within the ICRU recommendations of + 7% and - 5%.
The measured dose planes show much more variation around the field edges
and beam penumbra than in the central field region. The static case has a clinically
acceptable gamma pass rate over 95 % for a patient plan however that number drops
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significantly when the phantom is put in motion. The gamma analysis combined
with the 1D profile demonstrate that the CTV is receiving the expected dose co-
verage and hence is suitable for clinical use. The radiation oncologist should be
mindful however of both the higher than expected dose delivered to the lung total-
ling approximately 2.2 Gy, and the additional volume of lung that moves into the
treatment field, when planning on the exhale phase.
The profiles also demonstrate the importance of respiratory motion manage-
ment in the treatment of superior liver cancers with large displacement during the
respiratory cycle. The phantom motion is highly reproducible unlike the regular
breathing cycle of a person, particularly when the patient has morbidity associated
with liver cancers. If the patient was to breathe more deeply during the treatment
than they did during the 4DCT planning scan, the anatomy would be pushed more
inferiorly and exceed the treatment margins. It is possible that part or all of the
CTV could move out of the treatment field, thus reducing the tumour coverage.
Additional lung would also move into the treatment field and receive unplanned and
unnecessary dose. The ABC system allows the treatment staff to monitor the expi-
ration volume of the patient and interrupt the treatment field if the volume exceeds




VMAT is a technique that has been widely used for treatment of the prostate and
surrounding nodes within the POWH radiation oncology department, and more
recently the technique has been validated for use with a greater range of sites in-
cluding the pelvis, spine and scalp. VMAT has not yet been validated for use with
4D cases utilising respiratory management. The use of a VMAT technique may
offer several advantages over conformal techniques for 4D SBRT treatments of su-
perior liver lesions close to the lung. VMAT generally offers a more conformal plan
than 3D techniques due to the additional degrees of freedom during the planning
and calculation stage. A gantry arc allows many more angles of delivery and seg-
mentation provides the means for intensity modulation across structures. Inverse
planning also allows a planner to set additional parameters and dose objectives to
guide the treatment algorithm to find the best possible solution through an iterative
process. This often produces superior dose coverage of the PTV while limiting the
dose delivered to OARs, when compared to a manually forward-planned treatment
plan. This becomes particularly relevant for liver lesions that are close to critical
structures such as the lung, spinal cord and duodenum, and for SBRT treatments
in which large fractional doses are being delivered.
However, the dose delivery advantages become significantly less pronounced for
4D treatments. As the penumbra is spread significantly in the direction of motion
and the margins applied to the CTV are large, the conformality of the plan becomes
less relevant. Regardless, there are additional potential benefits of using a VMAT
technique even if the dose distributions fail to offer any significant advantage. Once
a VMAT template for this treatment site has been established it takes less time for
the planner to set up the beams and constraints for a VMAT plan than to set up
a conformal plan. Hence the number of plans created daily by a therapist could be
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increased by replacing conformal treatment plans with VMAT. This advantage may
be offset by the longer calculation times required for VMATs, particularly for Monte
Carlo systems like Monaco. The number of licenses and algorithm speed will affect
this. A second difference is that VMAT clinical deliveries are much faster than both
conformal and IMRT clinical deliveries which offers several advantages; The patient
spends less time on the bed which can both reduce intrafraction motion and incre-
ase the number of patients that can be treated within a specified time frame. This
benefits both the patient and the departmental resources. The associated disad-
vantage with this is that each VMAT treatment undertaken within the department
undergoes patient specific QA using phantom dosimetry.
An additional consideration for 4D treatments is the importance of IGRT. Accu-
rate patient localisation is a more significant issue for fields with intensity modula-
tion, particularly for SBRT, due to the steep dose gradients and small segment sizes.




The VMAT plan was created on the existing, contoured data set as described in
the conformal methods section with the same prescription and fractionation. The
plan was developed under the guidance of an experienced planning therapist based
on the current procedure for pelvic, 3D VMAT treatments. It should be noted that
at this stage the VMAT technique had not been released for liver treatments, nor
4D treatments. The plan was calculated with the Monte Carlo algorithm with a
single gantry arc from gantry angle 180o, rotating anticlockwise to 210o. The 330o
arc was selected based on current department VMAT treatment protocols and beam
templates. The following calculation properties were selected; grid spacing of 0.2
cm and statistical uncertainty of 1.00 % per calculation. The following sequencing
parameters were used; segment shape optimization selected, pilot beamlets selected,
maximum number of arcs of 1, minimum segment width of 1.00 cm and fluence
smoothing to medium.
The IMRT constraints were selected based on the regular approach to VMAT
treatment plans and generic OAR constraints designed to force modulation within
the plan, and are displayed in table 6.1.
The batch calculation and optimisation was then used to automatically create
segmentation and fluence maps. The resultant plan was deemed acceptable, and in
following with the conformal work flow, the plan was DICOM exported to Mosaiq
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Structure Cost Function Reference Dose Isoconstraint
(cGy) (cGy)
PTV Target Penalty 4000
Quadratic Overdose 4250
OAR 1 Serial 3000
OAR 2 Parallel 2500
External Quadratic Overdose 3800
Conformality 0.5
Table 6.1: Monaco VMAT plan IMRT constraints.
for treatment on the Axesse machine. The beam was added into the same treatment
course to allow the previously sent reference image data to be used for image gui-
dance. A QA plan was also created in Monaco to allow extraction of fractionated
dose data, and the beam arrangement was saved as a template.
6.2.2 Measurements
The VMAT ion chamber and film measurements were collected immediately follo-
wing the collection of conformal plan data. As such the same reference ion chamber
measurements and film calibration curve were used for analysis. The charge readings
were converted to point dose measurements using the average reference measurement
and normalised with respect to the planned dose for that position. The films were
analysed using the process described in the previous chapter and compared with
each other and the calculated dose plane.
6.3 Results
6.3.1 Point Dose Measurements
The point doses for VMAT fields were calculated as described for 3DCRT in Chapter
5 and the results are displayed in table 6.2. Similarly to the conformal experimen-
tation, the smallest difference of -0.3 % was observed for the static, exhale case.
The differences between the measured doses and the calculated dose at isocentre
were higher than for the 3DCRT case with a maximum difference of 2.1 % for the 8
bpm case. Contrary to the conformal case, the measured VMAT doses were higher
than the calculated dose. The differences from the prescribed dose were once again
within the ICRU guidelines for all point dose measurements.
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BPM Start Position Measured Dose Calculated Dose Difference
(Gy) (Gy) %
Static Exhale 8.368 8.396 -0.3
Static Inhale 8.427 8.396 0.4
14 Exhale 8.520 8.396 1.5
14 Inhale 8.538 8.396 1.7
23 Exhale 8.516 8.396 1.4
23 Inhale 8.559 8.396 1.9
8 Exhale 8.570 8.396 2.0
8 Inhale 8.579 8.396 2.1
Table 6.2: Comparison of Monaco calculated point dose and results measured
with ionisation chamber for VMAT plans.
6.3.2 Film Measurements
The results of the 2D dose plane comparisons for the various VMAT cases are
displayed in table 6.3. The analysis between the planned and measured static,
exhale case showed a lower pass rate of 94.0 % for the VMAT plan compared to
the corresponding 3DCRT plan. The gamma analysis showed the planning system
overestimated the dose in the lateral low-dose region, while there was a region of
hotter than expected points near the inferior PTV edge.
The comparison between the measured planes also showed similar variation than
those calculated for the conformal plan when started in the opposite breathing phase.
However, there was greater variation between the different breathing rates with the
lowest gamma pass rate at 95.0 % between the 14 bpm and 8 bpm exhale cases.
Plane 1 Plane 2 Pass rate (%)
Calculated Static Exhale Measurement 94.0
Calculated 8 bpm Exhale Measurement 22.7
Calculated 14 bpm Exhale Measurement 32.2
Calculated 23 bpm Exhale Measurement 43.0
8 bpm Inhale Measurement 8 bpm Exhale Measurement 95.3
14 bpm Inhale Measurement 14 bpm Exhale Measurement 99.8
23 bpm Inhale Measurement 23 bpm Exhale Measurement 97.3
14 bpm Exhale Measurement 8 bpm Exhale Measurement 95.0
14 bpm Exhale Measurement 23 bpm Exhale Measurement 96.0
Table 6.3: Comparison of both Monaco calculated dose plane, and film-measured
dose planes using gamma analysis.
1D profiles were taken from each dose plane and analysed and compared as
described in chapter 5.
Figure 6.1 shows a comparison between the calculated dose and the measured
dose under the planning conditions, with the phantom in the exhale position without
motion. The graph shows a higher discrepancy between the two profiles than those
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Figure 6.1: 1D comparison between the planned dose profile and measured
profile with the phantom in a static, exhale position.
in the corresponding conformal figure, with increased measured dose in both the
umbra region and low-dose region outside the field edge. Figure 6.2 shows the
profiles for the two static cases, inhale and exhale. The VMAT inhale static case
also shows the CTV coverage is inadequate in the inferior region when the phantom
is in the static inhale position. The profile shift corresponds to a 2.6 cm shift in
the phantom, with an increase in dose to the lung. The additional dose delivered
to lung reflects that given in the conformal case, however the dose increase at the
interface is less well defined with a shallower dose gradient for the VMAT case.
Figure 6.3 shows that, under motion, and regardless of the rate of respiration the
CTV is receiving the expected dose. In combination with graph 6.4 and the gamma
dose plane results, we see that the coverage is reproducible to within 5 % when
changing both the breathing rate and point in the cycle of beam-on. The dose to
the lung is up to 40 cGy higher than that calculated for the faster breathing rates in
the high dose region and significantly more dose delivered in the penumbra region
due to penumbra widening.
6.4 Discussion
Higher variation in the calculated and measured point doses are expected for the
VMAT plan when compared to the conformal plan due to the segmentation of the
beam. The VMAT field contains many small field segments, and steep dose gradients
exist within the plan due to intensity modulation. Small shifts from the point of
measurement can result in large observed dose differences, and this effect is magnified
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Figure 6.2: 1D comparison between the two static phantom position measured
profiles, in the exhale position (planned) and the inhale position.
Figure 6.3: 1D comparison between the measured profiles for each breathing
rate, starting in the exhale phase.
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Figure 6.4: 1D comparison between the dose profile and measured 14 bpm
profiles with the phantom starting on the exhale and inhale phase.
due to the 2.6 cm superior-inferior motion of the phantom.
The VMAT results showed lower reproducibility between the various measured
cases, although the gamma analysis yielded pass rates higher than 95 % for each
comparison. The dose plane and 1D dose profile results demonstrate that the CTV
is receiving the expected dose coverage for each case, implying VMAT is a clinically
viable treatment technique for these treatment conditions for this dose metric. An
additional 2 Gy is measured in the lower lung region, a lower additional dose to the
OAR than measured for the conformal case.
The distance from the inferior CTV edge to the start of the dose fall off ranges
between 0.5 and 3 mm across the profiles for different cases. This shows that respi-
ratory management is particularly necessary for patients of this treatment cohort,




The IMRT treatment technique is currently used within the department to treat a
wide range of treatment sites. The use of Step-and-Shoot IMRT for this treatment
site may offer a happy medium between VMAT and conformal techniques. IMRT
is limited to the same number of beam angles as a conformal treatment however
allows for modulation of intensity across the treatment volume and surrounding
tissue. As with VMAT, inverse planning is used to acquire a plan that may offer
significantly superior dose conformality when compared to a 3DCRT plan under
the same conditions. For 4D treatments, the dosimetric advantages of IMRT over
3DCRT are less pronounced due to the large extension of margins, particularly in
the superior-inferior direction.
Unlike VMAT deliveries, the Step-and-Shoot IMRT technique will generally
result in the patient being on the bed for an extended period than for a corresponding
3DCRT treatment. Step-and-Shoot IMRT still requires individual treatment plan
validation using linear arrays on the treatment machine, however the time required
both to deliver and process the measurements is significantly reduced. This allows
more plans to be verified by a physicist in the same time frame, particularly when
verification is required on 2 different machines.
Unlike Step-and-Shoot IMRT, VMAT has the additional advantage of reduced
treatment time, allowing for both increased patient throughput and reduced likeli-
hood of external patient motion. Is is likely then, that the step-and-shoot IMRT
technique shall only be given consideration for 4D SBRT liver treatments if a clear
dosimetric advantage can be demonstrated.
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7.2 Methods
7.2.1 Planning
An IMRT treatment plan was created on the CT data used in for the previous techni-
ques, with the prescription remaining constant. The Step and Shoot technique was
selected and the plan created based on both clinical protocol and the existing VMAT
plan. The parameters were kept as similar as possible to allow a more direct com-
parison between the VMAT and IMRT treatment plans. The Monaco Monte Carlo
algorithm was again used to calculate the plan with identical calculation proper-
ties. The following sequencing parameters were used; segment shape optimisation
selected, pilot beamlets selected, minimum segment area set to 4.0 cm2, minimum
segment width of 1.0 cm, fluence smoothing to medium, minimum number of MUs
per segment of 5, and maximum number of segments per plan of 80. The IMRT
constraints were the same as those used for the VMAT plan (see table 6.1). The
batch calculation and optimization tool was selected to automatically generate the
treatment plan, which was considered acceptable for verification purposes. The plan
was once again DICOM exported to Mosaiq for treatment on the Axesse linac, with
the original reference image data set. A Monaco QA plan was generated to compare
the fraction dose calculated to that delivered by the linac. The total calculated
point dose and coronal 2D dose planes were exported for comparison with measured
values.
7.2.2 Measurements
The IMRT ion chamber and film measurements were collected on a different day
to the collection of conformal and VMAT plan data. The measurements were once
again taken on the Elekta Axesse machine and new reference ion chamber measure-
ments were taken. A complete calibration curve was also measured with film taken
from the same batch as both the previous measurements and the IMRT dose planes.
Following alignment with CBCT, the ion chamber point dose measurements were
taken with the same CC04 chamber under the same conditions as measured for the
previous plans. The charge readings were converted to point dose measurements
using the average reference measurement and normalised with respect to the plan-
ned dose for that position. Eight 2D dose profiles were measured in the coronal
plane under the same conditions as described previously. The films were analysed
using the process described in Chapter 5 and compared with each other and the
Monaco-calculated dose planes.
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7.3 Results
7.3.1 Point Dose Measurements
The point doses for IMRT fields were also calculated as described in chapter 5 and
the results are displayed in table 7.1. Similarly to the other treatment technique
results, the smallest difference was observed for the static, exhale case. The IMRT
method had the highest variation of -0.9 %. The differences between the measured
doses and the calculated dose at isocentre were similar to those observed for the
VMAT technique with a maximum difference of 2.0 % In this method the highest
differences were seen for the fastest breathing rate. Contrary to the VMAT case,
the measured IMRT doses were lower than the calculated dose. With the exception
of the static inhale case, the deviation from prescribed dose was within - 5%.
BPM Start Position Measured Dose Calculated Dose Difference
(Gy) (Gy) %
Static Exhale 8.195 8.271 -0.9
Static Inhale 7.732 8.271 -7.0
14 Exhale 8.173 8.271 -1.2
14 Inhale 8.154 8.271 -1.4
23 Exhale 8.112 8.271 -2.0
23 Inhale 8.126 8.271 -1.8
8 Exhale 8.130 8.271 -1.7
8 Inhale 8.141 8.271 -1.6
Table 7.1: Comparison of Monaco calculated point dose and results measured
with ionisation chamber for step-and-shoot IMRT plans
7.3.2 Film Measurements
The results of the 2D dose plane comparisons for the various IMRT cases are dis-
played in table 7.2. The analysis between the planned and measured static, exhale
case yielded a pass rate of 95.8 %, lying between the VMAT plan and corresponding
3DCRT plan. The gamma analysis showed the planning system underestimated the
dose near the inferior PTV edge.
The comparison between the measured planes also showed a higher variation
than those calculated for both the conformal and VMAT plans when started in the
opposite breathing phase. The lowest pass rate was 91.3, showing a larger variation
in the dose distribution reproducibility for the same respiratory cycle. There was
however very little variation between the different breathing rates with the lowest
gamma pass rate at 99.6 %.
1D profiles were taken from each dose plane and analysed and compared as
described in chapter 5. Figure 7.1 shows a comparison between the calculated dose
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Plane 1 Plane 2 Pass rate (%)
Calculated Static Exhale Measurement 95.8
Calculated 8 bpm Exhale Measurement 19.7
Calculated 14 bpm Exhale Measurement 31.3
Calculated 23 bpm Exhale Measurement 32.1
8 bpm Inhale Measurement 8 bpm Exhale Measurement 92.5
14 bpm Inhale Measurement 14 bpm Exhale Measurement 99.5
23 bpm Inhale Measurement 23 bpm Exhale Measurement 91.3
14 bpm Exhale Measurement 8 bpm Exhale Measurement 99.8
14 bpm Exhale Measurement 23 bpm Exhale Measurement 99.6
Table 7.2: Comparison of both Monaco calculated dose plane, and film-measured
dose planes using gamma analysis
and the measured dose under the planning conditions. The graph shows reasonable
agreement between the two dose profiles, with deviations less than 2.5 %, except in
the inferior liver region in which the measured dose is 7 % higher than the calculated
dose. Figure 7.2 shows the profiles for the two static cases, inhale and exhale. The
underestimation of the measured dose by the planning system towards the inferior
border of the liver is likely due to the lack of backscatter at the phantom edge. The
IMRT inhale static case also shows the CTV coverage is inadequate in the inferior
region with a dramatic increase in absorbed dose to the lung.
Figure 7.3 shows that, under motion, and regardless of the rate of respiration
the CTV is receiving reasonable dose coverage, however there is greater variation
among the different breathing rates than was found for the previous techniques. In
combination with graph 7.4, the profiles show the CTV is receiving slightly lower
dose than predicted, with discrepancies up to 45 cGy per fraction. The IMRT plan
had tighter conformality around the superior field edge and did not exhibit a dose
peak in the lung region, however the significant broadening of the penumbra due to
motion results in additional dose.
7.4 Discussion
The static point dose and film measurements showed a higher deviation from the
planned dose than both the VMAT and conformal plans. The IMRT technique
had the highest deviation of coverage of the CTV compared to the expected dose
from the TPS. The IMRT measurements were also the least reproducible, with the
gamma analysis pass rates lower among the different breathing rates. This technique
however showed less dose delivered to the lung, with better coverage extending
superiorly from the CTV into the liver.
The IMRT technique shows little dosimetric advantage over the conformal techni-
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Figure 7.1: 1D comparison between the planned dose profile and measured
profile with the phantom in a static, exhale position.
Figure 7.2: 1D comparison between the two static phantom position measured
profiles, in the exhale position (planned) and the inhale position.
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Figure 7.3: 1D comparison between the measured profiles for each breathing
rate, starting in the exhale phase.
Figure 7.4: 1D comparison between the planned profile and measured 14 bpm
profiles with the phantom starting on the exhale and inhale phase.
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que with similar treatment delivery times. The inclusion of segmentation was not
enough to improve the dosimetric outcomes for the motion cases, when limited to
static gantry and collimator angles. Given patient plan verification is also required,
the advantages of this technique are negligible. Although this technique could po-
tentially be used for this treatment, VMAT appears to offer superior results. This is
consistent with current trends within the department, where measured VMAT plans
tend to agree better with Monaco calculated results than IMRT plans for similar
field and segment sizes. This could be due to a number of reasons associated with




8.1 Comparison of 3DCRT, IMRT and VMAT
Following the comparison of measured and calculated results for the three different
delivery techniques, a final comparison of the results can take place. The 1D dose
distribution graphs in the previous chapters show that the treatment margins are
sufficient to adequately cover the CTV for all techniques. A summary of the diffe-
rences found between the Monaco calculated point doses and those measured with
the ionisation chamber can be found in table 8.1. This data shows that 3DCRT
results in the most accurate point doses, and fall within the 0.5 % measurement
uncertainty. VMAT results in the greatest difference with an average difference of
1.8 %, measuring hotter than the calculated plan. IMRT has a similar difference of
1.6 % but measuring colder than the calculated plan. Interestingly, the signs are
reversed in the static case for both modulated cases.
BPM Start Position 3DCRT VMAT IMRT
% Difference % Difference % Difference
Static Exhale 0.1 -0.3 0.9
Static Inhale 1 0.4 -7.0
14 Exhale -0.3 1.5 -1.2
14 Inhale -0.5 1.7 -1.4
23 Exhale -0.4 1.4 -2.0
23 Inhale -0.3 1.9 -1.8
8 Exhale -0.3 2.0 -1.7
8 Inhale -0.3 2.1 -1.6
Average Non-Static -0.35 1.8 -1.6
Table 8.1: Comparison of differences found between Monaco calculated point
dose and results measured with ionisation chamber for each treatment technique.
A summary of the measured dose plans with gamma analysis is located in table
8.2. Once again, the 3DCRT results are the best, both for the true comparison
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between the exhale calculated plane and measured static plane, and between the
different moving cases. VMAT showed better agreement between inhale and exhale
measurements, while IMRT had greater agreement between the different breathing
rates, indicating interplay may effect the delivery techniques differently.
Plane 1 Plane 2 Pass rate (%)
3DCRT VMAT IMRT
Calculated Static Exhale Meas. 97.6 94.0 95.8
Calculated 8 bpm Exhale Meas. 32.7 22.7 19.7
Calculated 14 bpm Exhale Meas. 41.1 32.2 31.3
Calculated 23 bpm Exhale Meas. 31.5 43.0 32.1
8 bpm Inhale Meas. 8 bpm Exhale Meas. 98.5 95.3 92.5
14 bpm Inhale Meas. 14 bpm Exhale Meas. 94.1 99.8 99.5
23 bpm Inhale Meas. 23 bpm Exhale Meas. 99.4 97.3 91.3
14 bpm Exhale Meas. 8 bpm Exhale Meas. 99.8 95.0 99.8
14 bpm Exhale Meas. 23 bpm Exhale Meas. 99.6 96.0 99.6
Table 8.2: Comparison of both Monaco calculated dose plane, and film-measured
dose planes using gamma analysis for each treatment technique.
8.2 Discussion
Figures 5.8, 6.4 and 7.4 highlight one of the major limiting factors of the departmen-
tal planning technique, in which the plan is created on the exhale breathing phase
only. This results in a systemtic shift between the calculated dose distribution
and measurement and little consideration of the effect of moving tissue heteroge-
neities. This however is a limitation, stated previously, due to the vendor software
compatibility between the Monaco planning system and XVI IGRT system. The
free-breathing technique also results in a large ITV to encompass the CTV over the
full range of motion. Hence, while this project has determined the use of VMAT
as a viable alternative to 3DCRT for the current treatment protocol, ideally new
developments in the technique will allow for reductions in ITV and better compa-
risons between the planned and delivered dose distributions. Flattening-filter free
delivery (being commissioned within the department), is an alternative that will
potentially allow for breath-hold tehcniques, currently not possible due to the long
delivery times for SBRT fractions with conventional dose rates.
Chapter 9
Conclusions and Future Work
9.1 Conclusions
A custom, in-house phantom was designed and constructed to simulate the anatomy
and respiratory motion of a lung liver interface of an adult patient. Plans were
developed based on a cohort of SBRT liver patients treated previously within the
department. A static block phantom was also used to determine the effect of reduced
lateral scatter from a low density on the dose to adjacent normal tissue. The results
showed the effect was greatest at increasing depths and field sizes and the effect
reduced with increasing distance from the interface.
The validation of the current treatment protocol for liver tumours treated using
conformal, SBRT fields and respiratory management was investigated. It was found
the CTV was covered adequately with the expected dose as calculated by the treat-
ment system under motion. The accuracy of the TPS in modelling heterogeneities
is not significant in the motion cases due to the extensive broadening and shifting
of the dose plane. It was also determined the mean dose to lung measured is much
higher than calculated by the TPS. Each point dose measurement was found to dif-
fer from the calculated value by less than the ICRU recommendations of + 7% and
-5 %. The analysis of results also highlighted the importance of respiratory mana-
gement during radiotherapy treatment to ensure optimal dose delivery to both the
tumour volume and surrounding organs. The project provided evidence the current
practice for treating superior liver lesions is valid.
The viability of using a VMAT treatment technique for these tumour sites was
also investigated. Analysis of the measured dose distributions found the level of
coverage was similar to that found for the conformal plan for all breathing rates.
Based on the dose delivered to the CTV for all cases, VMAT was found to be a
viable alternative to conformal treatment. Because of the highly conformal nature
of the VMAT treatment, respiratory motion management was found to be essential
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in maintaining complete coverage of the CTV, particularly in the superior region.
The final experimental investigation examined the possibility of using Step-and-
Shoot IMRT. The IMRT plans proved to be less reproducible than both the VMAT
and conformal techniques, with lower gamma pass rates between the different cases.
A region of the CTV also received less dose than expected and hence this technique
offers little to no dosimetric advantage over 3DCRT for motion cases. Given that
Step-and-Shoot IMRT plans have a similar treatment delivery time to conformal
fields while requiring individual plan validation the author does not recommend
further validation of this technique.
Finally, the results of the experimentation showed that both the 4D imaging
and dosimetric outcomes were not significantly affected by the rate of respiration.
9.2 Future Work
While this project has established that VMAT is a viable treatment option for
superior liver lesion using respiratory management, the testing procedures are ina-
dequate to determine which method provides optimal dose constraints. In the plans
created for these experiments, the VMAT plan developed superior dose coverage
but an increased dose to organs at risk. A planning study should be undertaken
by experienced planning staff to determine which technique offers the best dosime-
tric outcomes. These outcomes should also be weighed against other departmental
factors including reduced treatment delivery time for VMAT, planning and calcu-
lation times, VMAT patient verification measurements and inability to use the 6D
positioning system with current 4D techniques.
A novel experiment to follow this project is to repeat the experiment with an
FFF treatment method. FFF is currently being commissioned for use in the Prince
of Wales Radiation Oncology department. An investigation into the viability of
FFF treatment would be required to assess the effect of the forward peaked beam
and significantly faster dose delivery times (approximately 4 times faster for 10 MV
Elekta beams).
Finally, measurements should be repeated for each of the treatment techniques
following implementation of gating within the department.
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